FDAnews Device Daily Bulletin

FTC CHALLENGES HOLOGIC/FISCHER IMAGING DEAL

July 12, 2006
A A

The Federal Trade Commission today announced its decision to challenge Hologic Inc.'s 2005 purchase of the breast cancer screening and diagnosis business of Fischer Imaging Corporation. In its complaint, the FTC alleged that Hologic's acquisition of Fischer's prone stereotactic breast biopsy systems (SBBSs) business harmed American consumers by eliminating its only significant competitor for the sale of SBBSs in the United States. In settling the Commission's charges, Hologic is required to sell the Fischer prone SBBS assets to Siemens AG, a leader in the business of medical imaging.

FTC (http://www.ftc.gov/opa/2006/07/hologic.htm)